Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2016-12, Vol.30 (12), p.2422-2426
Hauptverfasser:	Duncavage, E J, O'Brien, J, Vij, K, Miller, C A, Chang, G S, Shao, J, Jacoby, M A, Heath, S, Janke, M R, Elliott, K, Fulton, R S, Fronick, C, O'Laughlin, M, Westervelt, P, Ley, T J, Wilson, R K, Walter, M J
Format:	Artikel
Sprache:	eng
Schlagworte:	45/23 631/1647/514/2256 631/67/69 692/308/2056 692/308/575 692/699/67/1990/1673 692/700/139 Bone marrow Bone Marrow - pathology Cancer Cancer Research Critical Care Medicine Cytogenetics Diagnosis DNA sequencing Genes Genetic aspects Hematology Humans Intensive Internal Medicine Karyotypes Karyotyping letter-to-the-editor Letters to the editor Leukemia Medicine Medicine & Public Health Methods Monoclonal antibodies Mutation Myelodysplastic syndrome Myelodysplastic syndromes Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - pathology Nucleotide sequencing Oncology Oncology, Experimental
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!